|
|
|
|
New high performance ENT instruments from Riester
Riester has launched a range of ENT (ear, nose, throat) diagnostic instruments, the ri-scope L series of otoscopes and ophthalmoscopes.This new range was developed with input from medical doctors to ensure optical quality and an ergonomic design that is...
|
|
|
Control Gear Makes Excimer Lamps Easier to Integrate into Production Systems
The DBD 300/110-240 DIM electronic control gear with its patented pulsed mode to operate VUV emitting Xeradex excimer lamps has been designed for the 30W to 300W performance range.Among the control gear's innovations is the option of continuously variable...
|
|
|
Xenon Pharma-Company Report - new market report released
Refer to a friend 2010-02-04 13:21:04 - Xenon Pharma-Company Report - a new market research report on companiesandmarkets.com Xenon Pharma-Company Report is a private Company Report that provides up to date insight into the structure and operations...
|
|
|
Xenon Pharmaceuticals Inc.-Company Report - new market report released
Refer to a friend 2010-02-04 13:19:04 - Xenon Pharmaceuticals Inc.-Company Report - a new market research report on companiesandmarkets.com Xenon Pharmaceuticals Inc.-Company Report is a private Company Report that provides up to date insight into...
|
|
|
Fluorescence detectors for HPLC systems
new RF-20A and RF-20Axs fluorescence detectors provide sensitivity and validation support functions in a wide range of applications from conventional to ultra-fast LC analysis.Utilizing a newly designed optical system, the RF-20A and RF-20Axs have achieved...
|
|
|
Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke
Journal of Cerebral Blood Flow & Metabolism advance online publication, January 20, 2010.doi:10.1038/jcbfm.2009. Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke.
|
|
|
Integra LifeSciences Awarded Contract With HealthTrust Purchasing Group to Provide Luxtec(R) Surgica
PLAINSBORO, N.J., Jan.19, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation announced today that its subsidiary, Integra Luxtec, Inc., has signed a three-year contract with HealthTrust Purchasing Group to provide Luxtec(R) surgical...
|
|
|
Med BioGene Appoints World-Renowned Geneticist Dr. Michael R. Hayden as Director
Med BioGene Inc.(TSX VENTURE: MBI) is pleased to announce that Michael R. Hayden, MD, PhD, FRCPC, has joined the company's Board of Directors. Hayden is a Professor of Medical Genetics at the University of British Columbia (UBC), as well as the Director...
|
|
|
BRIEF: Appeals court upholds ruling for WARF
An appellate court has upheld a 2006 decision that awarded the Wisconsin Alumni Research Foundation $1 million in its case against a Canadian biotechnology company, the foundation said Wednesday.The U.S. Seventh Circuit Court of Appeals affirmed the award...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
By Scott Bauer, The Associated Press MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
By: Scott Bauer, THE ASSOCIATED PRESS MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Patenting arm at Univ. of Wis.-Madison wins lawsuit against Canadian drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Canadian drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how Xenon handled patent...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
|
|
Univ. of Wis.-Madison wins lawsuit against Vancouver drug company Xenon
MADISON, Wis.- The University of Wisconsin-Madison's patenting arm won an appeal Tuesday in federal court against Vancouver-based drug company Xenon. The lawsuit brought by the Wisconsin Alumni Research Foundation dealt with how privately held ...
|
